Samantha Malinowski Email and Phone Number

• Managed the sales of Genentech pharmaceuticals for the therapeutic areas of lung cancer and liver cancer in the Michigan region, addressing the specific needs of healthcare practitioners with the goal of improving patient outcomes, lowering costs and improving quality of care- Championed Genentech's corporate restructuring in Jan. 2020, forging new relationships cultivated previously by 12 Genentech representatives throughout Michigan• Launched Tecentriq in combination with Avastin… Show more • Managed the sales of Genentech pharmaceuticals for the therapeutic areas of lung cancer and liver cancer in the Michigan region, addressing the specific needs of healthcare practitioners with the goal of improving patient outcomes, lowering costs and improving quality of care- Championed Genentech's corporate restructuring in Jan. 2020, forging new relationships cultivated previously by 12 Genentech representatives throughout Michigan• Launched Tecentriq in combination with Avastin, the first and only cancer immunotherapy regimen approved by the FDA in May 2020, for the treatment of unresectable or metastatic hepatocellular carcinoma, the most common form of liver cancer- Led team which facilitated adoption of this new therapy at Karmanos Cancer Institute and Henry Ford Health System in Detroit and at Michigan Medicine in Ann Arbor- Cultivated key opinion leaders at Karmanos, Henry Ford and Michigan Medicine and supported them in advocating this new first-line treatment within the statewide healthcare community- Achieved 31% sales growth in 2020 and continuously exceed sales plan expectations• Sold a portfolio of infused and targeted oral oncolytic therapies for the treatment of the specific needs of each lung cancer patient Show less

Launched and sold the first Anti-PD-L1 inhibitor, Tecentriq (Atezolizumab), a cancer immunotherapy, to a diverse customer base including major academic centers, large hospitals, and community practices.Focus on clinical differentiation, in a very competitive environment.Cultivated relationships with regional thought leaders, serving as a resource in understanding their perspective of a rapidly emerging cancer immunotherapy market.Recognized for partnerships across the… Show more Launched and sold the first Anti-PD-L1 inhibitor, Tecentriq (Atezolizumab), a cancer immunotherapy, to a diverse customer base including major academic centers, large hospitals, and community practices.Focus on clinical differentiation, in a very competitive environment.Cultivated relationships with regional thought leaders, serving as a resource in understanding their perspective of a rapidly emerging cancer immunotherapy market.Recognized for partnerships across the Genentech BioOncology portfolio, finding ways to bring service and value to physicians, and patients through different internal program offerings.Awarded the prestigious Genentech Sales Consistency Award - 2017. Finishing 3 out of 5 consecutive years in the top 10% of Sales Professionals. Show less

Sold Rituxan and Actemra, biologic therapies for the treatment of severe rheumatoid arthritis, and other rare autoimmune diseases. Differentiated products from 9 major biologic competitors in the field.Sales Representative of the year 2012. #1 out of 65 representatives nationally. Sales Achievement winner 2012, 2014.Top 10% of sales representatives in the nation. Consulted with physicians, office staff, and infusion nurses regarding clinical education… Show more Sold Rituxan and Actemra, biologic therapies for the treatment of severe rheumatoid arthritis, and other rare autoimmune diseases. Differentiated products from 9 major biologic competitors in the field.Sales Representative of the year 2012. #1 out of 65 representatives nationally. Sales Achievement winner 2012, 2014.Top 10% of sales representatives in the nation. Consulted with physicians, office staff, and infusion nurses regarding clinical education, safety, efficacy, reimbursement solutions and access to care options. Show less

Endocrinology and Diabetes Sales Specialist

Managed $43M in sales and $50M in inventory, for 24 stores in 5 States. All prestige cosmetic and fragrance brands

Managed $15M in sales, accountable for 30 Clinique Counters in the state of Michigan. Hired and managed 30 Business Managers, 85 sales consultants. Responsible for sales, inventory flow, hiring and promotions.